The Wall Street Journal, the newspaper aimed most deliberately and 50 something men, weighs in heavily and wisely on the prostate cancer dilemma. The paper reports that when the New England Journal of Medicine recently asked readers how
they would treat a hypothetical 63-year-old man with a low-grade cancer
and a rising PSA (for prostate-specific antigen), the more than 3,720
physicians who responded split almost evenly among surgery, radiation
therapy and monitoring the cancer to see if it grew. With doctors so divided, the journal asks, how can patients know who to believe and what to do?
Good question. The story, the second in a two-part series on the many dilemmas that prostate cancer poses, (and the interactive graphic showing possible choices and likely side effects for those who have been diagnosed), is the best short work Geezer has seen. Highly recommended for all of the 185,000 men who will be told that they have prostate cancer this year.
Read more in the Wall Street Journal.
Health, fitness and lifestyle tips for people over 50 who still like to play hard
Saturday, May 31, 2025